Robotic Surgery Services Global Market Report 2024

The robotic surgery services market size has grown rapidly in recent years. It will grow from $1.01 billion in 2023 to $1.19 billion in 2024 at a compound annual growth rate (CAGR) of 17.8%. The expansion observed in the historical period can be ascribed to an increase in the adoption of surgical robots, the proliferation of healthcare facilities, supportive government regulations, heightened healthcare expenditures, and the rapid growth of the elderly population.

The robotic surgery services market size is expected to see rapid growth in the next few years. It will grow to $2.04 billion in 2028 at a compound annual growth rate (CAGR) of 14.4%. This anticipated growth in the forecast period is linked to several factors, including the surge in product launches, the prevalence of minimally invasive surgeries, an increasing incidence of chronic diseases, and a rise in healthcare expenditure. Key trends expected in the forecast period encompass the integration of in-vivo robots in surgery services, ongoing developments in technology, a rise in merger and acquisition activities, the utilization of nanobots in surgery services, and the application of artificial intelligence in robotic surgery services.

The growth of the robotic surgery services market is further propelled by the increased purchasing power of hospitals and ambulatory care services. These healthcare facilities are keen on acquiring the latest technologies to offer advanced care to patients and gain a competitive edge. For example, the industry giant Intuitive Surgical reported significant growth in the utilization of da Vinci Surgical Systems, with approximately 1,875,000 surgical procedures performed in 2022, representing an 18% increase compared to around 1,594,000 procedures in the previous year. Revenues from da Vinci Surgical Systems in the fourth quarter of 2022 reached approximately $1.66 billion, a 7% increase from $1.55 billion in 2021. The purchasing power of hospitals and ambulatory care services, combined with the aging population and the prevalence of chronic illnesses, has played a pivotal role in fostering the growth of the robotic surgery services market.


The anticipated growth of the robotic surgery services market is driven by the increasing incidence of chronic diseases. Chronic illnesses, characterized by lasting three months or more and potentially worsening over time, are being addressed through minimally invasive procedures offered by robotic surgery services. These procedures result in less pain, reduced scarring, and shorter recovery times compared to traditional open surgeries. For example, data from January 2023, according to the National Library of Medicine in the US, projects a 99.5% increase in the number of people aged 50 and older with at least one chronic condition, reaching 142.66 million by 2050. This rise in chronic diseases is a significant factor fueling the growth of the robotic surgery services market.

The combination of the image guide navigation system with robotic surgery systems is expanding possibilities for visualizing and conducting minimally invasive surgeries in challenging areas, particularly in orthopedic and neurosurgeries. Systems such as the Mazor X Stealth by Medtronic and NuVasive's Pulse and Excelsius GPS by Globus Medical use image-guided navigation systems for spine surgeries and orthopedic implant procedures, providing surgeons with a 3D experience. This technology reduces radiation exposure, eliminating the need for post-procedure X-rays. The image-guided navigation system is emerging as a trend in robotic surgery services.

Leading companies in the robotic surgery services market are dedicated to innovation, utilizing advanced technology to develop reliable products. The Da Vinci Xi Robotic Surgical System is an example of such innovation, offering an effective, minimally invasive alternative for a range of conditions, including cancer, colorectal disorders, gynecologic conditions, heart disease, head and neck disorders, thoracic disorders, and urological disorders. In June 2023, Apollo Hospitals Enterprise Limited, an India-based healthcare company, introduced the Da Vinci Xi Robotic Surgical System, equipped with HD cameras for superior visualization and enhanced dexterity surpassing the human hand.

In February 2022, Medtronic PLC., a US-based medical device company, acquired Digital Surgery for an undisclosed amount. This strategic move aims to bolster Medtronic's robotic-assisted surgery platform and broaden its portfolio of products. Digital Surgery, a UK-based pioneer in digital education, training, data and analytics, and surgical artificial intelligence (AI), brings valuable expertise to further enhance Medtronic's capabilities in the field.

Major companies operating in the robotic surgery services market report are Tenet Healthcare Corporation, HCA Healthcare, Inc., Asklepios Kliniken Verwaltungsgesellschaft Mbh, Apollo Hospitals Enterprise Ltd., Bumrungrad International Hospital, Fortis Healthcare, Bangkok Hospital, Spire Healthcare Group PLC, Saudi German Hospitals Group, Raffles Medical Group, SS Innovations Private Limited, Private Limited, CMR Surgical India Pvt. Ltd., Medicaroid Corp, Asahi Surgical Robotics Co Ltd., HOZ Medical, Medtronic Australasia, Taimi Robotics Technology, Wenshi Robot, Borns Medical RoboticsK, ewei Robot, Horizon Robotics, Avateramedical GmbH, Zimmer Biomet Robotics, Medtech SA, KB Medical SA, Senhance, Archer Daniels Midland Company, Barentz Group Companies, CHR Hansen , Asensus Surgical, Intuitive, Medrobotics Corporation, Medical Inc., Smith & Nephew, Restoration Robotics, Hansen Medical, RTI Connext DDS, Robotic Surgerya, Stryker Corporation, Mazor Robotics, Renishaw PLC, Stereotaxis Inc., Capsa Healthcare, ReWalk Robotics, Hocoma, Accuray Incorporated, Corindus, InTouch Health Inc.

North America was the largest region in the robotic surgery services market in 2023. Western Europe was the second largest region in the global robotic surgery services market share. The regions covered in the robotic surgery services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the robotic surgery services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The robotic surgery services market includes revenues earned by entities by providing robotic gynecological services, robotic prostate surgery services, robotic kidney surgery services, and robotic colorectal surgery services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.